PDS Biotechnology Corp — Form 8-K
Filed July 31, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
PDS Biotechnology Corp filed an 8-K on July 31, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, with Transfer of Listing noted. The filing provides no specific dollar amounts, percentages, share counts, or detailed reasons for the delisting notice. The company (market cap ~$60.1M) has triggered Nasdaq/NYSE continued listing compliance issues.
Why this rating
Delisting threat is existential for a $60M public company—eliminates capital markets access, shareholder liquidity, and institutional investor eligibility. Business-changing event regardless of underlying cause.
Extracted items
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.